Atrial fibrillation is the most common cardiac arrhythmia and increases the risk of conditions such as stroke and heart failure. An established treatment is catheter ablation, in which physicians use ...

Catheter ablation for atrial fibrillation (AF) did not significantly improve AF-related quality of life compared with a sham procedure, despite reducing AF recurrence. These were the main findings of ...

Catheter ablation is widely performed to treat atrial fibrillation (AF) but evidence on whether the procedure improves patients’ quality of life related to AF is lacking. In the PVI-SHAM-AF trial, ...

Lucas Kloberdanz-Dyck is a writer for Collider. He grew up creating lists, stories, and worlds, which led to his love of anime and video games. He attended Sheridan College where he earned an Honours ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved Johnson & Johnson’s dual energy AF ablation platform. The platform provides both radiofrequency ...

Johnson & Johnson announced Wednesday that the U.S. Food and Drug Administration approved its Dual Energy THERMOCOOL SMARTTOUCH SF Platform — a cardiac ablation catheter that, for the first time in a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Flutter valves are handheld devices that help people with chronic obstructive pulmonary disease (COPD) clear excess mucus from their airways. They work by combining positive expiratory pressure with ...

Johnson & Johnson has launched the Varipulse Pro in Europe following CE mark approval, further advancing its pulsed-field ablation (PFA) portfolio. This new pulse sequence marks the next evolution of ...

VARIPULSE Pro introduces a new pulse sequence with a lower temperature profile1,2,i and an ablation that is 5 times faster than the previous sequence3,ii, while achieving equivalent lesions4,v.

IRVINE, Calif.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced the launch of VARIPULSE Pro in Europe following CE Mark approval, further advancing its pulsed field ablation (PFA) ...